Inventor · disambiguated record
Douglas Harnish
Also filed as: HARNISH DOUGLAS · HARNISH DOUGLAS C · HARNISH DOUGLAS CARL
3 granted patents·10 pending applications·8 citations·filing 2001–2009
60Inventor score
Files withWYETH CORP13
Top patents by PatentIndex Score
13 records- 0176US7094559B1Assay to identify estrogen receptor dependent ligands that regulate the hepatic lipase promoterWYETH CORP·Filed 2001·Granted Aug 22, 2006·6 cites·30 claims
- 0270US7304073B2Method of treating myocardial ischemia-reperfusion injury using NF-kB inhibitorsWYETH CORP·Filed 2005·Granted Dec 4, 2007·2 cites·9 claims
- 0355US2009163474A1FXR Agonists for the Treatment of Nonalcoholic Fatty Liver and Cholesterol Gallstone DiseasesWYETH CORP·Filed 2008·Application pending·0 cites
- 0450US7521199B2Assay to identify estrogen receptor dependent ligands that regulate the hepatic lipase promoterWYETH CORP·Filed 2006·Granted Apr 21, 2009·0 cites·22 claims
- 0548US2005119276A1Methods of treating inflammatory bowel disease using NF-kB inhibitorsWYETH CORP·Filed 2004·Application pending·0 cites
- 0648US2005113405A1Methods of treating rheumatoid arthritis using NF-kB inhibitorsWYETH CORP·Filed 2004·Application pending·0 cites
- 0748US2008300235A1FXR Agonists for Reducing LOX-1 ExpressionWYETH CORP·Filed 2008·Application pending·0 cites
- 0844US2009311271A1Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1)WYETH CORP·Filed 2009·Application pending·0 cites
- 0944US2005256132A1Use of ER selective NF-kB inhibitors for the treatment of sepsisWYETH CORP·Filed 2005·Application pending·0 cites
- 1044US2005119324A1Methods of treating atherosclerosis using NF-kB inhibitorsWYETH CORP·Filed 2004·Application pending·0 cites
- 1143US2009215748A1FXR agonists for treating vitamin D associated diseasesWYETH CORP·Filed 2008·Application pending·0 cites
- 1242US2004167112A1Use of estrogen receptor alpha modulators for the treatment of multiple sclerosisWYETH CORP·Filed 2004·Application pending·0 cites
- 1339US2005221328A1Inhibitors of inflammatory gene activity and cholesterol biosynthesisWYETH CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas Harnish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →